Applications published 11 November 2009

Salts, aqueous liquid compsns containing slats of S-(+)-absiscic acid and methods of their preparation
Valent Biosciences 2114140*

Compounds and methods for treatment of alpha-1-antitrypsin deficiency
University of Florida 2114141*

Phytosanitary formulations
Centre National de la Recherche Scientifique (CNRS); Universite Blaise Pascal-Clermont-Ferrand II 2114142*

Phenylalkylcarboxylic acid delivery agents
Emisphere Technologies 2114145*

Reducing side effects of tramadol
DMI Biosciences 2114147*

• Combinations of dopamine D2 receptor blockade with norepinephrine reuptake inhibition and with norepinephrine alpha 2 receptor blockade
Green, Alan 2114150*

• Isomers of inositol niacinate and uses thereof
Concourse Health Sciences 2114151*

• Use of acetylated or esterificated azacytidine, decitabine or other nucleoside analogues as oral agents for the treatment of tumours or other dysplastic syndromes sensitive to hypomethylating agents
Nevada Cancer Institute 2114152*

• Treatment and prevention of neuro-degenerative diseases using gene therapy
Yoo, Tai June 2114153*

• Method of treating atherosclerosis, dyslipidaemias and related conditions
Merck 2114154*

• Enantiomers of amino-phenyl-acetic acid octadec 9-(Z)-enyl ester, their salts and their uses
Yeda Research and Development Co at the Weizmann Institute of Science 2114155*

• Chemical compounds, pharmaceutical compsns and methods
SmithKline Beecham 2114156*

• Phosphoramidate alkylator pro-drugs for the treatment of cancer
Threshold Pharmaceuticals 2114157*

• 3-substituted-[1,2,3]-benzotriazinone compounds for enhancing glutamatergic synaptic responses
Cortex Pharmaceuticals 2114158*

• Pesticidal mixtures based on azolopyrimidinylamines derivatives and insecticides
BASF  2114159*

• Antagonists of a non-selective cation channel in neural cells
University of Maryland 2114160*

• Insecticidal compounds
Syngenta Participations 2114161*

• Use of polymeric guanidines for controlling microorganisms
Aka Technology 2114164*

• Compounds, synthesis and methods of using indanone-based cholinesterase inhibitors
Reviva Pharmaceuticals 2114166*

• Non-human animals with human-glial chimeric brains
University of Rochester; Goldman, Steven; Windrem, Martha 2114167*

• Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent
Alzchem Trostberg 2114174*

• Olopatadine formulations for topical nasal administration
Alcon 2114367*

• Pharmaceutical compsns comprising a bisphosphonate compound
Besins Healthcare 2114368*

• Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases
Merz Pharma 2114369*

• Novel biomaterials for ocular drug delivery and a method of making and using the same
Allergan 2114370*

• Transport of drugs via the blood-brain barrier by means of apolipoproteins
LTS Lohmann Therapie-Systeme 2114371*

• Pharmaceutical carrier compsn and pharmaceutical compsn
Dafra Pharma 2114372*

• Dermatological emulsion and method for the preparation thereof
Pierre Fabre Dermo-Cosmetique 2114373*

• Pharmaceutical compsns of entacapone
Wockhardt Research Centre; Kalantri, Mahesh; Goswami, Sudhir; Murali, Narayanan; Jain, Girish 2114374*

• Rapidly-dispersible, particulate film coating agent based on polyvinyl alcohol-polyether graft copolymers
BASF 2114375*

• Amine polymer compsns
Genzyme 2114376*

• Controlled release of actives in skin
Rutgers, the State University of New Jersey 2114377*

• Method for releasing active ingredients in order to protect them and optimise their delivery mode
Coatex 2114378*

• Factor VII and VIIa compsns
Bayer HealthCare 2114379*

• Modified release pharmaceutical compsn and a process of making the same
Panacea Biotec 2114380*

• An oral sustained-release triple layer tablet
GL PharmaTech 2114381*

• Extended release dosage form
Mylan Pharmaceuticals 2114382*

• Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Acelrx Pharmaceuticals 2114383*

• Compsns and methods for enhancing transmucosal delivery
Derma-Young 2114384*

• Transdermal therapeutic system for administering water-soluble active ingredients
LTS Lohmann Therapie-Systeme 2114385*

• Pharmaceutical compsn for treatment of diabetic complications
Vlife Science Technologies 2114386*

• Use of compsns containing at least one lignane and/or neolignane for modulating testosterone levels
Europe Finances 2114387*

• Inhibitors of AKT activity
SmithKline Beecham 2114388*

• Methods and compsns for treating at least one upper gastrointestinal symptom
AGI Therapeutics 2114389*

• Methods for treating podocyte-related disorders
Reprecht-Karls-Universitaet Heidelburg 2114390*

• A preparation containing sodium butyrate and the application of a preparation containing sodium butyrate
Biolek 2114391*

• Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
Galderma Research & Development 2114392*

• Pharmaceutical compsns comprising trigonelline and 4-hydroxyisoleiucine and a process thereof
Indus Biotech Private 2114393*

• Platinum analogues with bis-nitrile-containing ligands
Bionumerik Pharmaceuticals 2114394*

• Ophthalmic and otic compsns of facially amphiphilic polymers and oligomers and uses thereof
Polymedix 2114395*

• Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
Medwell Laboratories 2114397*

• isosorbide mononitrate derivatives for the treatment of ocular hypertension
Lacer 2114398*

• R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma)
Cornerstone Therapeutics 2114399*

• Use of riluzone and derivatives thereof for producing new drugs
Association pour le Developpement de la Biotherapie Experimentale at Appliquee (A.D.B.E.A) 2114400*

• Cicletanine and PKC inhibitors in the treatment of pulmonary and cardiac disorders
Cornett, Glenn; Page, James; Jones, Wayne; Page, Karen 2114401*

• Benzimidazole derivatives and methods of use thereof
Schering 2114402*

• Treatment of cancers having resistance to chemotherapeutic agents
Bayer HealthCare 2114403*

• Pharmaceutical compound and compsn
Alphapharm 2114404*

• Crystalline forms GLYT1
F Hoffmann-La Roche2 2114405*

• Thioxanthene derivatives useful to treat infectious diseases
BKG Pharma 2114406*

• Use of sodium blockers for an early therapy of obstructive lung diseases
Universitaet Heidelburg 2114407*

• Substituted aminopyrimidines as cholecystokinin-1 receptor modulators
Merck 2114408*

• Compsn and method for treating or preventing skeletal muscle fibrosis
Agricultural Research Organisation 2114409*

• N-amino tetrahydrathiazine derivatives, method of manufacture and use
Women & Infants Hospital 2114410*

• Compsn and method for protecting mitochondria
Sucampo 2114411*

• Method of treating or preventing fertility in a female mammal and pharmaceutical kit for use in such method
Pantarhei Bioscience 2114412*

• Therapeutics for cancer ginsu 3-bromopyruvate and other selective inhibitors of ATP production
The Johns Hopkins University 2114413*

• Synthetic lipophilic inositol glycans for treatment of cancers and glucose-metabolism disorders
Trustees of Tufts College; Tohoku University 2114414*

• Methods and compounds for the targeted delivery of agents to bone for interaction therewith
University of Louisville Research Foundation 2114415*

• Method of inducing an immune response
The University of Queensland 2114416*

• New use of nitrites and nitrates and compsns containing these
Lundberg, Jon; Weitzberg, Eddie 2114417*

• Stabilised picoplatin oral dosage form
Poniard Pharmaceuticals 2114418*

• Use of arsenic compounds for treatment of pain and inflammation
Panaprix 2114419*

• Herpes simplex virus and methods of viral replication
Crusade Laboratories 2114420*

• Bacterial extract for respiratory disorders and process for its preparation
OM Pharma 2114421*

• Osteopontin for the prediction and treatment of cardiovascular diseases
National University of Ireland 2114422*

• Product containing inactivated probiotic for children or infants
Mead Johnson Nutrition Company 2114423*

• Solid betalain compsns and methods
VDF Futureceuticals 2114424*

• Integrated production of phytochemical rich plant products or isolates from green vegetation
Savangikar, Chitra; Savangikar, Vasant 2114425*

• Compsns and method of topical application and transdermal delivery of botulinum toxins stabilised with polypeptide fragments derived from HIV-TAT
Revance Therapeutics 2114426*

• Peptides for treatment of conditions associated with nitric oxide
New York University 2114427*

• Triazole macrocycle systems
Aileron Therapeutics 2114428*

• Compsns and methods to prevent cancer with cupredoxins
The Board of Trustees of the University of Illinois 2114429*

• TRPV1+ sensory neurons control of beta-cell stress and islet inflammation in diabetes
The Hospital for Sick Children 2114430*

• A compsn containing arazyme for the prevention and treatment of cancer
Insect Biotech 2114431*

• Methods of increasing cancer sensitivity to chemotherapeutic agents using chimeric ISF35
Memgen 2114432*

• Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation
Biogen Idec; CNRS (Centre National de la Recherche Scientifique); University Pierre and Marie Curie 2114433*

• Method for inducing thrombopoiesis
Nokad 2114434*

• Modulators of sclerostin binding partners for treating bone related disorders
Novartis 2114435*

• TRKB agonists for treating auto-immune disorders
Rinat Neuroscience Corp 2114436*

• Modified corticotropin releasing factor peptides and uses thereof
ConjuChem Biotechnologies 2114437*

• An insulintropic complex using an immunoglobulin fragment
Hanmi Pharmaceutical 2114438*

• Use of somatostatin analogues in cluster headache
Novartis 2114439*

• Use of fibrinogen as a prophylactic treatment to prevent bleeding during and after surgery and as a biomarker to identify patient wit an increased risk for excessive bleeding and blood transfusion
Jeppsson, Anders; Skrtic, Stanko; Bruce, Lennart; Johnsson, Joergen; Hedner, Thomas 2114440*

• The use of alkaline phosphatase in the treatment of reduced renal function
AM-Pharma 2114441*

• HAT acetylation promoters and uses of compsns thereof in promoting immunogenicity
The University of British Columbia 2114442*

• Dual-specific IL-1A/IL-1B antibodies
Abbott Laboratories 2114443*

• Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
University of Notre Dame 2114444*